VESTA
Live / Registered — Registered (as of 23 Dec 2025)
What this means for you
Registered since 23 Dec 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97251620
- Registration number
- 8078777
- Mark type
- Stylized text
- Filed
- 03 Feb 2022
- Published for opposition
- 18 Jul 2023
- Registered
- 23 Dec 2025
- Attorney of record
- Yvonne Y. Shyntum
Goods and services
- Class 001 — Chemicals: Biological tissue, namely, human or animal tissue and blood for use in scientific and medical research; Cell growth media for growing cells for scientific and research use
- Class 005 — Pharmaceuticals: Biological preparations for the treatment cancer and diseases of solid organs, namely, kidney, liver, heart, lung and pancreas, skin, intestines, stomach, spleen, bone, muscle, vascular, brain, and spinal cord; Pharmaceutical preparations for the treatment of cancer and for treatment of diseases of solid organs, namely, kidney, liver, heart, lung and pancreas, skin, intestines, stomach, spleen, bone, muscle, vascular, brain, and spinal cord; Cell growth media for growing cells for medical or clinical use
- Class 040 — Treatment of materials: Manufacturing services for others in the field of clinical grade media for therapy programs
- Class 042 — Scientific and technological services: Research and development in the biotechnology field
Owner
- Vesta Therapeutics, INC., Hanover, MD, US
- Vesta Therapeutics, INC., Hanover, MD, US
- Vesta Therapeutics, INC., Hanover, MD, US
Prosecution history
- 23 Dec 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Dec 2025 — REGISTERED-PRINCIPAL REGISTER
- 02 Dec 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Dec 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 25 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 25 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 01 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Jul 2025 — NON-FINAL ACTION E-MAILED
- 01 Jul 2025 — SU - NON-FINAL ACTION - WRITTEN
- 06 Jun 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Mar 2025 — USE AMENDMENT FILED
- 07 Jun 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 09 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2024 — SOU EXTENSION 2 GRANTED